VentureMed raises $15m in Series B

Vascular focused device developer VentureMed said today it raised $15 million in a Series B round. The round was led by newly invested Endeavour Vision and joined by RiverVest Venture Partners, the Toledo, Ohio-based company said. “Endeavour Vision’s current fund is dedicated to transformational technologies in medical devices and digital health. We are excited to support a company with the potential to make significant improvements in the lives of millions of men and women globally who suffer from peripheral vascular diseases and others suffering from the challenging management of renal dialysis access,” Endeavour Vision senior investment director Alexander Schmitz said in a prepared release. “RiverVest Venture Partners, is pleased to be participating in this financing. VentureMed’s innovative technology platform, partnered with its talented team, positions it to improve the treatment of PAD and AV access, and to significantly benefit physicians and their patients worldwide,” RiverVest Venture Partners VP Karen Spilizewski said in prepared remarks. VentureMed produces products designed for peripheral interventions for treating individuals with peripheral artery disease. The company’s Flex scoring catheter, designed for vessel preparation for interventional treatments for PAD, has both FDA clearance in the US and CE Mark approval in the European Union. “The Flex Scoring catheter is an innovative and promising technology for patien...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News venturemed Source Type: news